Coronavirus Update: Favipiravir Scores In Phase III Trial

Plus: UK Invests In 'At Risk' Vaccines Manufacturing.

 
• By Scrip Team

Glenmark's Phase III trial of the antiviral points to efficacy in mild-to-moderate COVID-19, but many physicians in India remain skeptical.  

Curfew
Miami Beach, South Florida. Night time curfews have been introduced to stem the spread of COVID-19, one of the US regions worst hit by the second spike in cases.

More from COVID-19

More from Scrip